ARISCAT, ASA and LAS VEGAS Risk Scores and the Incidence of Postoperative Pulmonary Complications in Thoracic Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital Nossa Senhora da Conceicao

About this trial

Postoperative pulmonary complications (PPC) are among the main complications after the anesthetic-surgical procedure. It can be said that thoracic surgery results in impaired respiratory function in the postoperatively, due to the decrease in lung volumes and capacities (the vital capacity decreases by approximately 50-60% and functional residual capacity decreases by approximately 30% in the first 24 hours after surgery) diaphragm dysfunction, gas exchange impaired, cough and ineffective mucociliary clearance. Thus, our hypothesis is that the application of preoperative risk scores normally used for non-cardiac and non-thoracic surgeries may be effective on the predictability of the occurrence of CPP in patients undergoing ventilation single-lung. This is a prospective observational study in order to evaluate the performance of the ASA, ARISCAT and LAS VEGAS risk scores for predict the occurrence of postoperative pulmonary complications (PPC) in patients undergoing thoracic surgery with single-lung ventilation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients undergoing any thoracic procedure associated with intraoperative single-lung ventilation.

Disqualifiers

Patients undergoing cardiac surgery, pregnant women, patient refusal, contraindications to proposed surgical, anesthetic or analgesic techniques, sepsis, psychiatric illness, uncontrolled endocrine, kidney or liver disease and coagulopathies.

Trial population

Adult patients undergoing any thoracic procedure associated with intraoperative use of single-lung ventilation.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Single-lung ventilation

    Procedure/Surgery

    Patients undergoing thoracic surgery and intraoperative single-lung ventilation.

Treatment groups

110 Participants
are divided into 1 treatment group
Group A: Group 11 intervention

Trial outcomes

Primary outcomes

1

Postoperative pulmonary complications

Incidence of composite pulmonary complications after surgery

Time frame
up to 30 days after surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.